The Use of Sun Protection After Hamam (Turkish Bath)
1 other identifier
interventional
12
1 country
1
Brief Summary
Hamam is a common spa treatment. During a Hamam, some of the outermost layer of the skin is removed. The investigators believe that partly removing a protective skin layer might increase the risk of sun burn, especially for skin that has not been exposed to sun for a long time. The aim with this study is to assess if Hamam-treated skin is more susceptible to sun burn compared with untreated skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2017
CompletedFirst Posted
Study publicly available on registry
May 12, 2017
CompletedStudy Start
First participant enrolled
May 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2017
CompletedAugust 9, 2017
August 1, 2017
2 days
May 11, 2017
August 8, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Skin erythema
Change in skin erythema: comparison of Hamam treated skin with untreated skin. Photographs of the skin will be assessed by computer analysis.
Baseline until 24 hours after sun exposure.
Secondary Outcomes (2)
Skin erythema
Baseline until 24 hours after sun exposure.
Pain
Baseline until 24 hours after sun exposure.
Study Arms (2)
Hamam treated skin and sun exposure
ACTIVE COMPARATORUntreated skin and sun exposure
OTHERInterventions
Hamam is a skin treatment (soaping and scrubbing).
Skin that will not receive Hamam.
Eligibility Criteria
You may qualify if:
- ≥18 years
- Healthy volunteers
- Skin types 1,2,3- Fitzpatrick scale
- Provided informed consent
You may not qualify if:
- Regular medication for a condition/disease
- Active skin disease
- Sun exposure on the back within four weeks prior to the start of the study
- History of premalignant or malignant skin lesions
- Tattoo covering more than half of the back
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Herlev and Gentofte Hospital
Herlev, 2730, Denmark
Study Officials
- STUDY CHAIR
Jacob Rosenberg, Professor
University of Copenhagen, Herlev Hospital
- PRINCIPAL INVESTIGATOR
Stina Öberg, MD
University of Copenhagen, Herlev Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD student
Study Record Dates
First Submitted
May 11, 2017
First Posted
May 12, 2017
Study Start
May 12, 2017
Primary Completion
May 14, 2017
Study Completion
May 14, 2017
Last Updated
August 9, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share